Join Free For Buyer|Sign In
CPhI&P-MEC

API, Preparation and Pharmaceutical Machinery and Equipment from Professional Online Trade Platform _EN-CPhI.cn

All Categories
Here’s the Chance?! A Core Patent of Novartis’ Entresto in China is Fully Declared Invalid

Here’s the Chance?! A Core Patent of Novartis’ Entresto in China is Fully Declared Invalid

Tim Freeman's Powder Flow Feature: Embracing QbD and PAT

Tim Freeman's Powder Flow Feature: Embracing QbD and PAT

CPhI China 2018

CPhI China 2018

Guilin Sanleng Biotech Co., Ltd.

Guilin Sanleng Biotech Co., Ltd.

PMEC China 2018

PMEC China 2018

Latest Products More>>

LiaoNing Oxiranphex Inc.
Shanghai Tofflon Science and Technology Co., Ltd.

Featured Suppliers More>>
Trade Opportunities More>>

Chinese Market More>>
Current Situation of Biosimilars in China III: Analysis of Biosimilars of Five Blockbusts

Current Situation of Biosimilars in China III: Analysis of Biosimilars of Five Blockbusts

The biosimilars in China just started, and the biosimilar review and approval policies continue to be improved.

Current Situation of Biosimilars in China II: 2016-2020 will be the Prime Time of Biosimilars

Current Situation of Biosimilars in China II: 2016-2020 will be the Prime Time of Biosimilars

The Chinese biosimilar market can reach RMB 20-30 billion in 2020...

Industry News More>>
Current Situation of Biosimilars in China II: 2016-2020 will be the Prime Time of Biosimilars

Opdivo May Be the First Marketed in China, Chinese Pharmaceutical Enterprises are Catching up Fast!

Data Reports
5 Worthwhile M&A Targets for 2018

46 New Drugs: The Number of New Drugs Marketed in 2017 Set a New Record for Recent 20 Years

FDA approved 11 new drugs in total (see the attached table for the details) in 2017 Q3. Time is the most objective judge and good things will always stand its tests.

Events More>>
Follow Us
CPhI Online Trade Platform: CPhI.cn | En-CPhI.cn | CPhI-Online.com
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)

Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53